MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ajh/hpt074

Медицинская библиотека · American journal of hypertension · 2013

Urinary albumin excretion at follow-up predicts cardiovascular outcomes in subjects with resistant hypertension.

Oliveras Anna, Armario Pedro, Sierra Cristina, Arroyo José A, Hernández-del-Rey Raquel, Vazquez Susana, Larrousse María, Sans Laia, Roca-Cusachs Alejandro, de la Sierra Alejandro

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Renal function and albuminuria predict cardiovascular disease (CVD) in general population. However, their prognostic value in patients with resistant hypertension (RH) is somewhat unknown.

OBJECTIVE

To determine the ability of renal function and albuminuria to predict CVD in RH patients.

METHODS

One hundred and thirty-three RH (blood pressure [BP] ≥140/90mmHg despite treatment with ≥3 drugs) patients were evaluated. Median follow-up was 73 months. Primary endpoint was a composite of non-fatal cardiovascular events or cardiovascular death. Serum creatinine (SCr) and estimated glomerular filtration rate (eGFR) were determined. Microalbuminuria was defined as a urinary albumin-to-creatinine ratio (UACR) ≥30mg/g.

RESULTS

Twenty-two patients (16.5%) reached the primary endpoint. Long-term elevated UACR (66 vs. 17mg/g, P=0.045), but not at baseline, was associated with the primary endpoint, after adjusting for age, prior CVD, and both eGFR and office systolic-BP at baseline and during follow-up. Although baseline SCr and eGFR were associated with CVD, significance was lost after baseline risk adjustment. Baseline microalbuminuria prevalence was 45% and 41% in patients with and without CVD (P=0.813), while percentages of patients with microalbuminuria at follow-up were 67% and 28%, respectively (P=0.002). More patients with de novo CVD, compared with those without CVD, developed microalbuminuria at follow-up (28% vs. 6%) or had persistent microalbuminuria (39% vs. 21%), while fewer patients with CVD had microalbuminuria regression (11% vs. 19%) or remained normoalbuminurics (22% vs. 53%; overall P=0.005).

CONCLUSION

In RH patients, the inability to microalbuminuria regression, either due to persistence or new appearance, independently predicts CVD.

Для цитирования: Oliveras Anna, Armario Pedro, Sierra Cristina, Arroyo José A, Hernández-del-Rey Raquel, Vazquez Susana, Larrousse María, Sans Laia, Roca-Cusachs Alejandro, de la Sierra Alejandro. Urinary albumin excretion at follow-up predicts cardiovascular outcomes in subjects with resistant hypertension.. American journal of hypertension. 2013. DOI: 10.1093/ajh/hpt074.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.